FindTrial
Sign In

Cross-Over Evaluation of Two Lubricating Eye Drops

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00493662
Enrollment
Unknown
Registered
2007-06-28
Start date
Unknown
Completion date
Unknown
Last updated
2008-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye

Brief summary

To evaluate the efficacy of two lubricating eye drops for the treatment of dry eye signs and symptoms.

Interventions

DRUGPolyethylene Glycol 400 0.4%
DRUGPropylene Glycol 0.3%
DRUG0.15% sodium Hyaluronate
DRUGsodium chloride
DRUGsodium phosphate monobasic

Sponsors

Innovative Medical
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

1. Patients 18 yrs or older 2. Males or females 3. Any race or ethnic background 4. Patients with present ocular surface discomfort and a SESoD score of at least 2

Exclusion criteria

1. Corneal refractive surgery within 6 months of this study. 2. Contact lens use on day of examination. 3. Corneal ectasia. 4. Current use of Restasis

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026